Search filters

List of works by Sophie Park

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q).

scientific article published on 26 February 2013

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.

scientific article published on 16 January 2013

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

scientific article published on 01 July 2019

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire ⬇️

scientific article published on March 7, 2013

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

scientific article

Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review

scientific article published on 13 December 2018

Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide.

scientific article published on 19 August 2010

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS ⬇️

scientific article published on July 30, 2011

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.

scientific article

Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation

scientific article

Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?

scientific article published in February 2013

IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia

scientific article published on 29 July 2010

Leukemic phase of follicular lymphomas: an atypical presentation.

scientific article published on 17 May 2011

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.

scientific article published on 16 January 2013

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.

scientific article published on 5 February 2013

Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

scientific article published on 28 July 2010

The autoimmune manifestations associated with myelodysplastic syndrome respond to 5‐azacytidine: a report on three cases ⬇️

scientific article published on January 31, 2011

The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemia.

scientific article published on 14 October 2011

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

scientific article published on 25 October 2019

Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate

scientific article published on 01 June 2019

p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes.

scientific article

Paulina is supported by:

About Paulina

Help